Your Article Summary
See Latest ArticlesSeverity of Hypoalbuminemia Predicts Response to Intradialytic Parenteral Nutrition in Hemodialysis Patients
Journal of Renal Nutrition, 06/19/09
Dezfuli A et al. - Improvement of hypoalbuminemia occurs in most hypoalbuminemic MHD patients who receive IDPN therapy. The likelihood and magnitude of the response to IDPN are associated with the severity of baseline hypoalbuminemia. These associations need to be verified in controlled trials.
Related Articles
Psoas abscess in hemodialysis patients
International Urology and Nephrology, 10/06/09
Relevance Score: 90%
Improved Nutrition After Conversion to Nocturnal Home Hemodialysis
Journal of Renal Nutrition, 10/14/09
Relevance Score: 89%
Permanent Hearing Loss With Iopamidol Following Aortic Angiography in a Hemodialysis Patient: A Case Report and Review of the Literature
American Journal of Kidney Diseases, 10/28/09
Relevance Score: 87%
Prevalence and Cardiovascular Features of Japanese Hemodialysis Patients with Fabry Disease
American Journal of Nephrology, 10/16/09
Relevance Score: 87%
Revised Dyadic Adjustment Scale as a Reliable Tool for Assessment of Quality of Marital Relationship in Patients on Long-Term Hemodialysis
Iranian Journal of Kidney Diseases, 10/13/09
Relevance Score: 87%
Today in Dialysis...keeping you current
Receive free subspecialty "5-minute updates" via email
Continuous venovenous haemodialysis (CVVHD) and continuous peritoneal dialysis (CPD) in the acute management of 21 children with inborn errors of metabolism
Nephrology Dialysis Transplantation, 12/03/09
Does hepatitis C increase the accumulation of advanced glycation end products in haemodialysis patients
Nephrology Dialysis Transplantation, 12/03/09
The role of polymer surface degradation and barium sulphate release in the pathogenesis of catheter-related infection
Nephrology Dialysis Transplantation, 12/03/09
Today in Radiology/Diagnostics...keeping you current
Receive free subspecialty "5-minute updates" via email
Chronic kidney disease in Tasmania
Nephrology, 12/03/09
Connective Tissue Growth Factor-(CTGF, CCN2) - A Marker, Mediator and Therapeutic Target for Renal Fibrosis
Nephron: Experimental Nephrology, 12/03/09
Determinants of Resistive Index Shortly after Transplantation: Independent Relationship with Delayed Graft Function
Nephron: Clinical Practice, 12/02/09